A Singapore-based research team is cautioning diabetics to be mindful of what apps, if any, they’re using to manage their condition after an analysis found the majority of such aids lack the ability to effectively monitor a patient’s diet, activity, medications, glucose and insulin.

White women—but not black women—between the ages of 65 and 74 carried a lower risk of stroke than their male counterparts in a U.S. study, suggesting gender-specific protections against stroke vanish earlier among blacks.

General Electric (GE) has filed the paperwork for an initial public offering (IPO) for its healthcare unit, GE Healthcare, according to numerous sources familiar with the ongoing situation. The offering is expected to take place by the middle of 2019.

Low-dose vaginal estrogen therapy—a treatment used to relieve genital and urinary discomfort in women during menopause—isn’t associated with an elevated risk of cardiovascular disease or cancer, researchers reported in Menopause Dec. 17.

Patients who receive heart surgery experience minimal changes to their memory up to two years after their operations compared to those who undergo less-invasive cardiac catheterization, according to a new study, offering reassurance that postoperative cognitive decline may be temporary in many cases.

An analysis of more than 3.5 million percutaneous coronary intervention (PCI) patients found the procedure was initially popular with an older demographic starting in 1998, but after 2006 the overall number of PCIs in those aged 70 and up started to decline.

Several professional societies collaborated to release appropriate use criteria for peripheral artery intervention (PAI), a field the authors acknowledged still has an emerging evidence base that is likely to change these recommendations in the future.

U.S. Surgeon General Jerome Adams, MD, issued a rare national advisory Dec. 18 deeming youth e-cigarette use an “epidemic” in the country.

The calcium-channel blocker nicardipine can effectively reverse coronary slow flow (CSF)—“an under-recognized cause of chest pain”—according to the authors of a study published online Dec. 15 in the Journal of Invasive Cardiology.

In a medical landscape where just a fraction of clinical trial participants are diverse in their race, sex, lifestyle or genetics, a team of physicians have published a paper detailing how their peers can ramp up efforts to recruit a more representative pool of patients.